Acorah Software Products - Accounts Production 19.3.550 false true 30 November 2024 1 December 2023 false 1 December 2024 30 November 2025 30 November 2025 11064423 Mrs E K Rennie Dr C S Rennie iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11064423 2024-11-30 11064423 2025-11-30 11064423 2024-12-01 2025-11-30 11064423 frs-core:CurrentFinancialInstruments 2025-11-30 11064423 frs-core:Non-currentFinancialInstruments 2025-11-30 11064423 frs-core:ComputerEquipment 2025-11-30 11064423 frs-core:ComputerEquipment 2024-12-01 2025-11-30 11064423 frs-core:ComputerEquipment 2024-11-30 11064423 frs-core:FurnitureFittings 2025-11-30 11064423 frs-core:FurnitureFittings 2024-12-01 2025-11-30 11064423 frs-core:FurnitureFittings 2024-11-30 11064423 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2025-11-30 11064423 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-12-01 2025-11-30 11064423 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-11-30 11064423 frs-core:PlantMachinery 2025-11-30 11064423 frs-core:PlantMachinery 2024-12-01 2025-11-30 11064423 frs-core:PlantMachinery 2024-11-30 11064423 frs-core:SharePremium 2025-11-30 11064423 frs-core:ShareCapital 2025-11-30 11064423 frs-core:RetainedEarningsAccumulatedLosses 2025-11-30 11064423 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11064423 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 11064423 frs-bus:SmallEntities 2024-12-01 2025-11-30 11064423 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 11064423 frs-bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 11064423 frs-core:DeferredTaxation 2024-12-01 2025-11-30 11064423 frs-core:DeferredTaxation 2024-11-30 11064423 frs-core:DeferredTaxation 2025-11-30 11064423 frs-bus:Director1 2024-12-01 2025-11-30 11064423 frs-bus:Director2 2024-12-01 2025-11-30 11064423 frs-countries:EnglandWales 2024-12-01 2025-11-30 11064423 2023-11-30 11064423 2024-11-30 11064423 2023-12-01 2024-11-30 11064423 frs-core:CurrentFinancialInstruments 2024-11-30 11064423 frs-core:Non-currentFinancialInstruments 2024-11-30 11064423 frs-core:SharePremium 2024-11-30 11064423 frs-core:ShareCapital 2024-11-30 11064423 frs-core:RetainedEarningsAccumulatedLosses 2024-11-30
Registered number: 11064423
Romsey Medical Practice Limited
Unaudited Financial Statements
For The Year Ended 30 November 2025
Peter Jarman LLP
Romsey Medical Practice Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
Romsey Medical Practice Limited
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 11064423

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 235,376 |  | 265,134
|  |  | 235,376 |  | 265,134
CURRENT ASSETS
Debtors | 5 | 78,327 |  | 29,922 |
Cash at bank and in hand |  | 179,670 |  | 142,440 |
|  | 257,997 |  | 172,362 |
Creditors: Amounts Falling Due Within One Year | 6 | (90,358 ) |  | (65,090 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 167,639 |  | 107,272
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 403,015 |  | 372,406
Creditors: Amounts Falling Due After More Than One Year | 7 |  | (24,203 ) |  | (40,842 )
PROVISIONS FOR LIABILITIES
Deferred Taxation |  |  | (43,305 ) |  | (46,192 )
NET ASSETS |  |  | 335,507 |  | 285,372
CAPITAL AND RESERVES
Called up share capital | 9 |  | 111 |  | 111
Share premium account |  |  | 249,989 |  | 249,989
Profit and Loss Account |  |  | 85,407 |  | 35,272
SHAREHOLDERS' FUNDS |  |  | 335,507 |  | 285,372

Page 1
Page 2
Romsey Medical Practice Limited
Balance Sheet (continued)
As At 30 November 2025
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr C S Rennie Director
18/08/2026

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Romsey Medical Practice Limited
Notes to the Financial Statements
For The Year Ended 30 November 2025
Notes to the Financial Statements
1. General Information
Romsey Medical Practice Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11064423 . The registered office is St James' Hall, Mill Road, Lancing, West Sussex, BN15 0PT.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Leasehold | 20% on cost and straight line over 15 years
Plant & Machinery | 25% on reducing balance
Fixtures & Fittings | 25% on reducing balance
Computer Equipment | 25% on reducing balance

2.4. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred.
2.5. Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred Tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
2.6. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
Page 3
Page 4
Romsey Medical Practice Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 November 2025
3. Average Number of Employees
Average number of employees, including directors, during the year was: 6 (2024: 6)
6 6
4. Tangible Assets

| Land & Property
--- | ---
| Leasehold | Plant & Machinery | Fixtures & Fittings | Computer Equipment | Total
| £ | £ | £ | £ | £
Cost
As at 1 December 2024 | 277,781 | 113,000 | 12,848 | 21,095 | 424,724
Additions | - | - | 500 | 1,499 | 1,999
As at 30 November 2025 | 277,781 | 113,000 | 13,348 | 22,594 | 426,723
Depreciation
As at 1 December 2024 | 68,669 | 69,825 | 9,030 | 12,066 | 159,590
Provided during the period | 17,457 | 10,794 | 937 | 2,569 | 31,757
As at 30 November 2025 | 86,126 | 80,619 | 9,967 | 14,635 | 191,347
Net Book Value
As at 30 November 2025 | 191,655 | 32,381 | 3,381 | 7,959 | 235,376
As at 1 December 2024 | 209,112 | 43,175 | 3,818 | 9,029 | 265,134

5. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 10,954 |  | -
Other debtors | 67,373 |  | 29,922
| 78,327 |  | 29,922

6. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Net obligations under finance lease and hire purchase contracts | - |  | 7,756
Bank loans and overdrafts | 5,022 |  | 10,000
Other loans | 11,617 |  | 11,617
Other creditors | 23,194 |  | 9,139
Taxation and social security | 50,525 |  | 26,578
| 90,358 |  | 65,090

Page 4
Page 5
Romsey Medical Practice Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 November 2025
7. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Bank loans | - |  | 5,022
Other loans | 24,203 |  | 35,820
| 24,203 |  | 40,842

8. Provisions for Liabilities

| Deferred Tax | Total
--- | --- | ---
| £ | £
As at 1 December 2024 | 46,192 | 46,192
Deferred taxation | (2,887 ) | (2,887 )
Balance at 30 November 2025 | 43,305 | 43,305

9. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 111 |  | 111

Page 5